tbuckley/cabot-search huggingface dataset:
Trends in Collection and Utilization of Autologous Hematopoietic Stem Cells (APBHC) Intended for Transplant in Patients with Multiple Myeloma
Authors: Nina Samuel, Lauren Laufer, Rodrigo Tanaguchi, Joel Rosiene, Carlo Palesi, Richard Elkind, Ioannis Mantzaris, Aditi Shastri, Noah Kornblum, R. Alejandro Sica, Urvi A Shah, Dennis Cooper, Amit Verma, Nishi Shah
Journal: Blood (2022)
Sequential Use of Flamsa, FLAG, CLAG or TEC-Based Conditioning Regimen Followed By Allogeneic Hematopoietic Transplantation Results in Favorable Outcome for High Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myeloproliferative Neoplasia Patients: 15 Year Follow-up of the Multicenter Study in Singapore
Authors: Lip Leong Chong, Yang Liang Boo, Yin Jie Koh, Joanne Lee, Michelle Limei Poon, Jeffrey Quek, Hein Than, Yeh Ching Linn, William YK Hwang, Aloysius YL Ho, Lip Kun Tan, Liang Piu Koh
Journal: Blood (2022)
Utility and Validity of Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) in Predicting Overall Survival and Non-Relapse Mortality in Adolescent and Young Adult Population
Authors: Ali Alsugair, Syed O. Ahmed, Mohamed Isam Sharif, Tusneem Elhassan, Hazza A. Alzahrani, Fahed Almhareb, Naeem A. Chaudhri, Fahad Alsharif, Walid Rasheed, Amr Hanbali, Feras Abdulaziz Alfraih, Marwan Shaheen, Riad El Fakih, Saud Alhayli, Ali Alahmari, Alfadel Alshaibani, Abdulwahab Albabtain, Ahmad S. Alotaibi, Mansour Alfayez, Mahmoud Aljurf
Journal: Blood (2022)
Colorectal Cancer Screening in Patients with Inherited Bleeding Disorders: High Cancer Detection Rate in Hemophilia Patients
Authors: Eva Kempers, Calvin B. van Kwawegen, Joke de Meris, Saskia E.M. Schols, Paula F. Ypma, Floor C.J.I. Moenen, Lize F.D. Van Vulpen, Michiel Coppens, Johanna G. van der Bom, Karin Fijnvandraat, Karina Meijer, Jeroen C.J. Eikenboom, Samantha C. Gouw, Frank W.G. Leebeek, Marieke J.H.A. Kruip
Journal: Blood (2022)
Epigenetic Priming with 5-Azacytidine Prior to Allogeneic Stem Cell Transplantation for Myeloid Malignancies with <i>In Vivo</i> T Cell Depletion: Results of a Phase II Trial
Authors: Mohammad Alhomoud, Usama Gergis, Adrienne A. Phillips, Jingmei Hsu, Zhengming Chen, Alexandra Gomez-Arteaga, Tsiporah B. Shore, Joseph Scandura, Koen Van Besien, Sebastian A. Mayer
Journal: Blood (2022)
Haploidentical Transplant Using Selective <i>Ex-Vivo</i> Tcrαβ Depleting and Memory T Cell Add-Back Results in More Favorable Gvhd-Free /Relapse Free Survival (GRFS) As Compared to Post-Transplant Cyclophosphamide for Adults with Hematological Malignancies - a Comparative Analysis of 170 Patients in a Multicenter Study in Singapore
Authors: Victor Ling Wei Teik, Yeh Ching Linn, Michelle Limei Poon, Jeffrey Quek, Lip Kun Tan, Zi Yi Lim, Colin Phipps Diong, Balamurugan Vellayappan, Joanne Lee, William YK Hwang, Hein Than, Aloysius YL Ho, Ian Wu, Yang Liang Boo, Teck Guan Soh, Gina Gan, Yvonne Su Ming Loh, Yin Jie Koh, Liang Piu Koh
Journal: Blood (2022)
Long-Term Outcomes of a Clinical Trial of Molecular and Functional Drug Screening for Individualized Therapy in Relapsed and Refractory (R/R) Acute Leukemia (AL)
Authors: Piyanuch Kongtim, Mary-Elizabeth M. Percival, Timothy J Martins, Guangrong Qin, Niall Curley, Kelda M. Gardner, Sylvia Chien, Jin Dai, Vivian G. Oehler, C. Anthony Blau, Paul C. Hendrie, Ryan D. Cassaday, Anna B. Halpern, Bart L. Scott, Roland B. Walter, Heather Smith, Guido Marcucci, Pamela S. Becker
Journal: Blood (2022)
Rituximab Induces an Inflammatory Cytokine Response with Increased IP-10 (CXCR10) in Patients with Infusion Reactions
Authors: Clive S. Zent, Jeremiah E. Moore, Paige C. Bloom, Charles C. Chu, Jennifer E. Bruno, Christine A. Herne, Andrea M Baran, Sally A. Quataert, Tim R. Mosmann, Ronald P. Taylor, Danielle S. Wallace, Michael R. Elliott, Paul M. Barr
Journal: Blood (2022)
Elevated FDG Uptake in the Lung Is a Characteristic Finding of Intravascular Large B-Cell Lymphoma
Authors: Shinpei Harada, Hideki Goto, Hajime Senjo, Keito Suto, Shiro Watanabe, Yuko Uchiyama, Koh Izumiyama, Masayo Yamamoto, Kazuya Sato, Yasutaka Kakinoki, Tomoyuki Saga, Akio Shigematsu, Hiroto Horiguchi, Mutsumi Takahata, Reiki Ogasawara, Satoshi Yamamoto, Keisuke Yamaguchi, Kentaro Wakasa, Tetsuyuki Igarashi, Yoshihito Haseyama, Shinichi Ito, Katsuya Fujimoto, Junichi Hashiguchi, Masao Nakagawa, Takanori Teshima
Journal: Blood (2022)
Demographic and Clinical Characteristics of Multiple Myeloma Patients in Latin America
Authors: Vania T.M. Hungria, Damila Trufelli, Jaqueline Saes, Karina Nakajima, Lays Leonel, Rafael Gaiolla, Kenny Galvez, Guillermina Remaggi, Rosane Bittencourt, Angelo Maiolino, Natalia Paola Schutz, Guillermo Quintero
Journal: Blood (2022)
Real World Treatment Outcomes for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant in Different Income Countries within Asia Pacific Region
Authors: Chin Sum Cheong, Sen Mui Tan, Soo Chin Ng, Tee Chuan Ong, Sharifah Shahnaz Syed Abd Kadir, Kim Wah Ho, Alan Teh, Haris Abdul Rahman, Ping Chong Bee, Naomi Aoki, Pin-Yen Chen, Erica M. Wood, Andrew Spencer, Elizabeth M. Moore, Wee Joo Chng, Gin Gin Gan
Journal: Blood (2022)
Luspatercept for Treatment of Lower Risk Myelodysplastic Syndromes: Real World Data Replicates Medalist Study Results and Confirms Activity Among Hypomethylating Agents and Lenalidomide Treated Patients
Authors: Rami S. Komrokji, Najla Al Ali, Somedeb Ball, Onyee Chan, Andrew Kuykendall, Kendra Sweet, Jeffrey E. Lancet, Eric Padron, David A. Sallman
Journal: Blood (2022)
Longitudinal Single Cell Multiomic Analysis of a Patient with <i>GATA2</i> Haploinsufficiency with <i>ASXL1</i> Mutant Clonal Hematopoiesis
Authors: Alejandro Ferrer, Rekha Mudappathi, Terra Lasho, Ryan M. Carr, Jenna A. Fernandez, Christy Finke, Naseema Gangat, Roshini S. Abraham, Moritz Binder, Abhishek A. Mangaonkar, Junwen Wang, Mrinal M. Patnaik
Journal: Blood (2022)
Impact of FLT3 Inhibitor-Based Therapies on Outcomes of Acute Myeloid Leukemia (AML) Patients Receiving Allogenic Stem Cell Transplantation: A Retrospective Study
Authors: Krithika Chennapan, Karam Ashouri, Anastasia Martynova, Samvel Nazaretyan, Amir Ali, Eric Tam, Abdullah Ladha, Karrune Woan, Preet M. Chaudhary, Imran Siddiqi, George Yaghmour
Journal: Blood (2022)
COVID-19 Associated 60-Day Acute VTE Events in Hospitalized Patients Can be Predicted By D-Dimer and Prior VTE but Not By Reticulated Platelets
Authors: Bilal Ashraf, Haekyung Jeon-slaughter, Nicholas C.J. Lee, Taha Bat, Sung-Hee Choi, Weina Chen, Abey Thomas, Ibrahim F. Ibrahim
Journal: Blood (2022)
Clinical Genomic Analyses Demonstrate t(11;14) Multiple Myeloma Retains B-Cell Biology and Distinct Mitochondrial Metabolism That Convey Increased Sensitivity to BCL-2 Inhibition By Venetoclax
Authors: David Sharon, Fengjiao Dunbar, Paul Jung, Xifeng Wang, Xiaotong Li, Christine Mantis, Orlando F. Bueno, Cyrille Touzeau, Philippe Moreau, Simon J Harrison, Luciano J. Costa, Jonathan L. Kaufman, Nizar J. Bahlis, Shaji K Kumar, Jeremy A. Ross, P.K. Epling-Burnette
Journal: Blood (2022)
Neutrophil to Lymphocyte Ratio (NLR) at Diagnosis Is a Predictor of Venous Thrombosis and Poor Outcome in Patients with Prefibrotic Primary Myelofibrosis
Authors: Fabrizio Cavalca, Francesca Palandri, Novella Pugliese, Alessia Ripamonti, Ambra Di Veroli, Mattia Biondo, Carlo Gambacorti-Passerini, Roberto Latagliata, Elena Maria Elli
Journal: Blood (2022)
Allogeneic Blood or Marrow Transplantation (AlloBMT) with High-Dose Post-Transplantation Cyclophosphamide (PTCy) for Acute Lymphoblastic Leukemia (ALL) in Patients Aged ≥ 55: Best Results in B ALL in First Remission (CR1) with Reduced-Intensity Conditioning (RIC)
Authors: Jonathan Allen Webster, Madison C. Reed, Hua-Ling Tsai, Alexander J. Ambinder, Tania Jain, Amy E. DeZern, Mark J. Levis, Margaret M. Showel, Gabrielle T. Prince, Christopher S. Hourigan, Javier Bolaños-Meade, Lukasz P. Gondek, Gabriel Ghiaur, William Brian Dalton, Suman Paul, Ephraim J. Fuchs, Christian B. Gocke, Abbas Abbas Ali, Douglas E. Gladstone, Carol Ann Huff, Ivan M. Borrello, Lode J. Swinnen, Nina D. Wagner-Johnston, Richard F. Ambinder, Leo Luznik, Ivana Gojo, B. Douglas Douglas Smith, Ravi Varadhan, Richard J. Jones, Philip H. Imus
Journal: Blood (2022)
Integrative Genomic and Transcriptomic Profiling Reveals Distinct Molecular Subsets in Adult Mixed Phenotype Acute Leukemia
Authors: Qian Wang, Haiping Dai, Wenzhi CAI, Qinrong Wang, Zhu Mingqing, Lingzhi Yan, Yan Yu, Hongjie Shen, Yang Xu, Ying Wang, Miao Miao, Shengli Xue, Yue Han, Xiaowen Tang, Huiying Qiu, Aining Sun, Jinyan Huang, Depei Wu, Suning Chen
Journal: Blood (2022)
Molecular Clustering on Ctdna May Improve Prognostic Stratification of DLBCL Patients
Authors: Riccardo Moia, Chiara Favini, Donatella Talotta, Riccardo Dondolin, Mohammad Almasry, Riccardo Bruna, Samir Mouhssine, Irene Della Starza, Roberta Soscia, Alessio Bruscaggin, Lodovico Terzi Di Bergamo, Annalisa Andorno, Francesca Mercalli, Abdurraouf Mokhtar Mahmoud, Clara Deambrogi, Silvia Rasi, Luigi Petrucci, Teresa Bellissimo, Renzo Boldorini, Alice Di Rocco, Ilaria Del Giudice, Maurizio Martelli, Valter Gattei, Davide Rossi, Robin Foa, Gianluca Gaidano
Journal: Blood (2022)
A Retrospective, Matched Paired Analysis Comparing GBM/GBC Versus BEAM/Beac Conditioning Regimen for Autologous Stem Cell Transplantation in Non-Hodgkin's Lymphoma
Authors: Huimin Liu, Hesong Zou, Wei Liu, Wenyang Huang, Shuhui Deng, Rui Lv, Weiwei Sui, Yan Xu, Shuhua Yi, Tingyu Wang, Mingwei Fu, Gang An, Yaozhong Zhao, Lugui Qiu, Dehui Zou
Journal: Blood (2022)
Recurrent <i>DNMT3B</i> Alterations Are Associated with Unfavorable Outcome in Dicentric (9;20)-Positive Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
Authors: Željko Antić, Alena van Bömmel, Konstantin Riege, Jana Lentes, Charlotte Schröder, Julia Alten, Lara Fuhrmann, Martin Zimmermann, Cornelia Eckert, Gunnar Cario, Martin Schrappe, Brigitte Schlegelberger, Steve Hoffmann, Anke K. Bergmann
Journal: Blood (2022)
Real-World Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Standard of Care: A Cota Database Analysis
Authors: Andrew Ip, Alex Mutebi, Tongsheng Wang, Monika P. Jun, Anupama Kalsekar, Fernando Rivas Navarro, Anthony Wang, Rajesh Kamalakar, Mariana Sacchi, Brian Elliott
Journal: Blood (2022)
Effect of Predicted Fludarabine Lymphodepletion Exposure on Clinical Outcomes in Myeloma Patients Undergoing BCMA-CAR-T: An Exploratory Analysis from CARTITUDE-1
Authors: Karen Sweiss, Pritesh Patel, Janet Guo, Kyeongmin Kim, Jordan M Schecter, Christina Y Sheng, Dawei Song, Xiaoying Xu, Yaming Su, Weirong Wang, Deepu Madduri, Carolyn C Jackson, Enrique Zudaire, Tzu-min Yeh, Tito Roccia, Dong Geng, Lida Pacaud, Douglas W Sborov, Mitch A Phelps, Craig C Hofmeister
Journal: Blood (2022)
Prospective Study of the Usefulness of Liquid Biopsy in Patients with Unknown Fever Suspected of Malignant Lymphoma
Authors: Akinao Okamoto, Masashi Sanada, Takahiko Yasuda, Seiichi Kato, Akira Satou, Kosei Matsue, Hiroki Hosoi, Masahiro Yoshida, Satsuki Murakami, Eisei Kondo, Yasufumi Masaki, Yasuhiro Suzuki, Kana Miyazaki, Tomohiro Kajiguchi, Junji Hiraga, Shingo Kurahashi, Yuichiro Inagaki, Kazutaka Ozeki, Shigeki Saito, Toshiki Terao, Sachiko Iba, Keiko Hattori, Hideyuki Yamamoto, Naoe Goto, Chisako Iriyama, Masataka Okamoto, Akihiro Tomita
Journal: Blood (2022)
CD84: A Novel Target for CAR T-Cell Therapy for Acute Myeloid Leukemia
Authors: Lorena Pérez-Amill, Mercedes Armand-Ugon, Sergio Peña, Maria Val Casals, Claudio Santos, Gerard Frigola, Alfredo Minguela, Àlex Bataller Torralba, Berta Casanovas, José Álamo, Mireia Uribe, Diego Sánchez-Martínez, Néstor Tirado, Clara Bueno, Paola Alejandra Romecín, Pablo Menéndez, Antonio Martínez, Montserrat Rovira, Jordi Esteve, Álvaro Urbano-Ispizua, Julio Delgado, Manel Juan, Nela Klein-González
Journal: Blood (2022)
TP53 Gene Deletion or Mutation in Newly Diagnosed Multiple Myeloma Patients By FISH with Cytoscan Arrays and Targeted Panel Sequencing
Authors: Hongying You, Hongjie Shen, Song Jin, Qingqing Wang, Shuang Yan, Yingying Zhai, Weiqin Yao, Xiaolan Shi, Jingjing Shang, Lingzhi Yan, Ying Yao, Jing Wang, Panfeng Wang, Jinlan Pan, Depei Wu, Chengcheng Fu
Journal: Blood (2022)
A Phase II, Single-Arm Study of De-Escalation and Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Treated with Nilotinib in First-Line Therapy Followed By a Second Attempt after Nilotinib and Asciminib Combination: Dante Study
Authors: Gianantonio Rosti, Giuseppe Saglio, Fabio Stagno, Diletta Valsecchi, Aurelio Pio Nardozza, Paola Coco, Massimo Breccia, Alessandra Iurlo
Journal: Blood (2022)
Rapid Response to Idecabtagene Vicleucel in a Myeloma Patient Refractory to Multiple Prior Lines of Anti-BCMA Directed Therapies
Authors: Maximilian Merz, Vladan Vucinic, Song Yau Wang, Christina Kloetzer, Birthe Schetschorke, Jan Sonntag, Jule Ussmann, Saskia Hell, Simone Heyn, Sandra Hoffmann, Enrica Bach, Klaus H. Metzeler, Sebastian Schwind, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Uwe Platzbecker
Journal: Blood (2022)
A First-in-Human Phase I Study of CTX-712 in Patients with Advanced, Relapsed or Refractory Malignant Tumors - Hematologic Malignancies Dose Escalation Cohort
Authors: Hisayuki Yokoyama, Koji Ando, Noriko Fukuhara, Hiroatsu Iida, Suguru Fukuhara, Hiroshi Miyake, Yasushi Tanoue, Maki Yamamoto, Hirokazu Tozaki, Akio Mizutani, Daisuke Morishita, Kunihiko Takeyama, Toshio Shimizu, Noboru Yamamoto
Journal: Blood (2022)
Preclinical Development of Hosu-53, a Novel Potent Dihydroorotate Dehydrogenase Inhibitor with Impressive Single Agent Efficacy and Combination Approaches in Hematological Malignancy
Authors: Erin Hertlein, Chad Bennett, Ola A Elgamal, Sandip Vibhute, Sharyn Baker, Thomas E Goodwin, Don M. Benson, Christopher Coss, Jeffrey Patrick, Gerald Hilinski, John C. Byrd
Journal: Blood (2022)
Belantamab Mafodotin in Combination with Vrd for the Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Patients: Results from the Phase II, Open Label, Multicenter, GEM-BELA-Vrd Trial
Authors: Veronica Gonzalez-Calle, Paula Rodriguez Otero, Beatriz Rey-Bua, Javier De La Rubia, Felipe De Arriba, Valentin Cabañas, Esther González Garcia, Enrique M. Ocio, Cristina Encinas, Alexia Suarez Cabrera, Joan Bargay, Joaquin Martinez Lopez, Marta Sonia Gonzalez, Jose Angel Hernandez-Rivas, Laura Rosiñol, Miguel-Teodoro Hernández, Bruno Paiva, Maria Teresa Cedena Romero, Noemi Puig, Juan-José Lahuerta, Joan Bladé, Jesús San-Miguel, Maria-Victoria Mateos
Journal: Blood (2022)
STAT3 Protects Hematopoietic Stem and Progenitor Cell Function in Non-Inflamed Conditions
Authors: Bhakti Patel, Yifan Zhou, Rachel L Babcock, Feiyang Ma, Yusra B Medik, Laura M Kahn, Josue E Pineda, Elizabeth Park, Karen Clise-Dwyer, Simona Colla, Stephanie S Watowich
Journal: Blood (2022)
Comparison of Next-Generation Flow Cytometry (NGF) and Next-Generation Sequencing (NGS) in the Assessment of Minimal Residual Disease in Multiple Myeloma
Authors: Qingqing Wang, Li Yao, Mingqing Zhu, Lingzhi Yan, Song Jin, Jingjing Shang, Xiaolan Shi, Yingying Zhai, Shuang Yan, Weiqin Yao, You Hongying, Depei Wu, Chengcheng Fu
Journal: Blood (2022)
Bioprocessing of MIR17HG Results in Long and Short Noncoding RNAs with Targetable Tumor-Promoting Activity in Multiple Myeloma
Authors: Eugenio Morelli, Annamaria Gulla, Na Liu, Domenico Maisano, Anil Aktas-Samur, Nicola Amodio, Caroline Ribeiro, Leon Wert-Lamas, Jonathan Henninger, Srikanth Talluri, Megan Johnstone, Doriana Gramegna, Delaney Vinaixa, Antonino Neri, Dharminder Chauhan, Teru Hideshima, Masood A. Shammas, Pierfrancesco Tassone, Sergei Gryaznov, Richard A. Young, Kenneth C. Anderson, Carl D. Novina, Massimo Loda, Mariateresa Fulciniti, Mehmet K. Samur, Nikhil C Munshi
Journal: Blood (2022)
Impact of FDA-Approved Novel Agents for Steroid-Refractory Chronic Graft-Vs. Host Disease on Treatment Patterns and Outcomes - a Single Center Longitudinal Cohort Analysis
Authors: Gil Fridberg, Odelia Amit, Chen Karni, Dina Tshernichovsy, David Shasha, Vanessa Rouach, David Verssano, Amir Bar-Shai, Gilad Wasserman, Ilan Goldberg, Irit Avivi, Ron Ram
Journal: Blood (2022)
Treatment Patterns, Tolerance, and Clinical Response of Chronic Phase Chronic Myeloid Leukemia (CML-CP) Patients (Including Those Harboring the T315I Mutation) Experiencing Multiple Tyrosine Kinase Inhibitor Failure: A Multi-Center Retrospective Chart Review Analysis
Authors: Franck E. Nicolini, Francoise Huguet, Lynn Huynh, Churong Xu, Christophe Bouvier, Aurore Yocolly, Gabriel Etienne
Journal: Blood (2022)
Inotuzumab Ozogamicin Induction Followed By Standard Chemotherapy Yields High Remission Rates and Promising Survival in Older (&amp;gt;55 Years) Patients with De Novo B-Lymphoblastic Leukemia (GMALL-Initial1 Trial)
Authors: Matthias Stelljes, Nael Alakel, Ralph Wäsch, Sebastian Scholl, Kathrin Nachtkamp, Andreas Rank, Mathias Haenel, Bernd Spriewald, Maher Hanoun, Sonja Martin, Katjana Schwab, Julian Knaden, Lena Reiser, Julia Marx, Klaus Wethmar, Tim Sauer, Wolfgang E. Berdel, Georg Lenz, Monika Brüggemann, Simon Raffel, Nicola Goekbuget
Journal: Blood (2022)
Real-World Treatment Patterns and Outcomes after Ibrutinib Discontinuation Among Elderly Medicare Beneficiaries with Chronic Lymphocytic Leukemia: An Observational Study
Authors: Scott F. Huntington, Enrico De Nigris, Justin Puckett, Sachin Kamal-Bahl, Mohammed Z.H. Farooqui, Katherine Elizabeth Ryland, Eric Sarpong, Xiaoqin Yang, Jalpa Doshi
Journal: Blood (2022)
U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPs Study): Inhibitor Development and Treatment Characteristics
Authors: Shannon L Carpenter, Martin Chandler, Michael F Guerrera, Lynn Malec, Matthew Manuel, Michael Recht, Ulrike Reiss, Robert F. Sidonio, Jr., Cristina Tarango, Marijke Van den Berg, Michael Wang, Courtney D. Thornburg
Journal: Blood (2022)
Co-Occurrence of High-Risk Lesions Is a Consistent Predictor of Ultra-High Risk Multiple Myeloma in Newly Diagnosed and Relapsed/Refractory Patients - Meta-Analysis of 5,808 Trial Patients
Authors: Martin F. Kaiser, Pieter Sonneveld, David Cairns, Marc S Raab, Alessandra Larocca, Sarah R Brown, Marc-A. Baertsch, Cong Li, Pellegrino Musto, Kwee Yong, Elias K Mai, Andrea Capra, Gordon Cook, Hartmut Goldschmidt, Mario Boccadoro, Graham Jackson, Niels Weinhold, Francesca Gay
Journal: Blood (2022)
Tocilizumab for the Management of Cytokine Release Syndrome after Haploidentical Hematopoietic Transplant with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis
Authors: Janny M. Yao, Hanna Kim, Dongyun Yang, Sally Mokhtari, Salman Otoukesh, Shukaib Arslan, Idoroenyi Amanam, Brian J Ball, Paul B. Koller, Amandeep Salhotra, Ahmed Aribi, Andrew S. Artz, Ibrahim Aldoss, Haris Ali, Anthony S. Stein, Guido Marcucci, Stephen J Forman, Ryotaro Nakamura, Monzr M. Al Malki
Journal: Blood (2022)
Frequent Early Geriatric Complications after Allogeneic Hematopoietic Cell Transplantation (HCT) in Older Adults Impairs Disability-Free Survival (DiFS)
Authors: Jorge M. Ramos Perez, Haoyue Shan, Dongyun Yang, Leana Cabrera Chien, Carolina Uranga, Jaroslava Salman, Ibrahim Aldoss, Haris Ali, Ahmed Aribi, Saro H. Armenian, Shukaib Arslan, Vinod A. Pullarkat, Amandeep Salhotra, Karamjeet S. Sandhu, Ricardo Spielberger, Anthony S. Stein, Guido Marcucci, Monzr M. Al Malki, Stephen J Forman, William Dale, Ryotaro Nakamura, Andrew S. Artz
Journal: Blood (2022)
Acquired Loss of a Sex Chromosome Is a Positive Prognostic Factor for Patients with Multiple Myeloma Undergoing ASCT
Authors: Simon Husby, Morten Tulstrup, Mads Harsløf, Christian Nielsen, Marianne Antonius Jakobsen, Eva Kannik Hastrup, Lene Hyldahl Ebbesen, Mette Klarskov Andersen, Maroulio Pertesi, Björn Nilsson, Carsten Utoft Niemann, Agoston Gyula Szabo, Niels Frost Andersen, Niels Abildgaard, Kirsten Grønbæk, Annette Juul Vangsted
Journal: Blood (2022)
Assessing the Burden of Adverse Events in a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia (CLL)
Authors: John F. Seymour, John C. Byrd, Talha Munir, Paolo Ghia, Arnon P. Kater, Asher Chanan-Khan, Richard R. Furman, Susan O'Brien, Jennifer R. Brown, Anthony R. Mato, Stephan Stilgenbauer, Thomas Fehn, Paulo Andre P. de Miranda, Kara Higgins, Ellie John, Marianne de Borja, Wojciech Jurczak, Jennifer A. Woyach
Journal: Blood (2022)
Abatacept/Tacrolimus or Abatacept/Tacrolimus/Post-Transplant Cyclophosphamide Are Safe and Highly Effective in Preventing Graft-Versus-Host Disease in Matched or Mismatched Donor Peripheral Blood Stem Cell Transplantation
Authors: Vladimir I. Vorobyev, Anton Yu. Subora, Yulia A. Oleinik, Lev S. Butaev, Vera A. Zherebtsova, Darya G. Kisilichina, Margarita A. Ulyanova, Evdokiya S. Urnova, Alena M. Sukhareva, Matvei P. Bulusov
Journal: Blood (2022)
In Hospital Mortality of Thrombotic Microangiopathy in Patient with HIV: A Retrospective Cohort Study from National Inpatient Sample (2016-2019)
Authors: Calvin Ghimire, Nischit Baral, Tejaswi Vinjam, Simi M. Mathew, Sajan Acharya, Rohit Rauniyar, Krishna Prasad Bashyal, Ujwala Koduru, Joshua Christy, Arvind Kunadi
Journal: Blood (2022)
Prognostic Significance of Chromosomal Genomic Array Testing in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia
Authors: Noam E. Kopmar, Xiaoyu Qu, Yajuan J. Liu, Ted A. Gooley, Lucas Zarling, Mary-Elizabeth M. Percival, Cristina Ghiuzeli, Min Fang, Ryan D. Cassaday
Journal: Blood (2022)
Outcomes Post-Allogeneic Hematopoietic Cell Transplantation Relapse in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Authors: Tamer Othman, Ibrahim Aldoss, Ni-Chun Tsai, Hoda Pourhassan, Vaibhav Agrawal, Salman Otoukesh, Idoroenyi Amanam, Dat Ngo, Jason Chen, Monzr M. Al Malki, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Karamjeet S. Sandhu, Shukaib Arslan, Brian J Ball, Forrest M. Stewart, Peter T. Curtin, Andrew S. Artz, David S Snyder, Guido Marcucci, Stephen J Forman, Anthony S. Stein, Ryotaro Nakamura, Vinod A. Pullarkat, Matthew Mei, Paul B. Koller
Journal: Blood (2022)
Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-Atpase (<i>PSMC</i>) Gene Family Transmit Proteasome Inhibitor Resistance in Multiple Myeloma By Impacting the ADP/ATP Binding Pocket
Authors: Larissa Haertle, Hipolito Nicolas Cuesta Hernandez, Natalia Sofia Buenache, Michal Simicek, Renata Snaurova, Inmaculada Rapado, Nerea Martinez, Nieves López-Muñoz, Jose Maria Sanchez-Pina, Rafael Colmenares, Margarita Sanchez-Beato, Miguel Angel Piris, Ivan Plaza Menacho, Mehmet Kemal Samur, Nikhil C Munshi, Rosa Ayala, K. Martin Kortuem, Santiago Barrio, Joaquin Martinez-Lopez
Journal: Blood (2022)
Phase 1 Clinical Trial of Memory-Enriched Academic HSP-CAR30 for the Treatment of Relapsed/Refractory Hodgkin Lymphoma and CD30+ T-Cell Lymphoma: Clinical and Biological Studies
Authors: Ana Carolina Carolina Caballero Gonzalez, Laura Escribà-García, Rosanna Montserrat, Eva Escudero-López, Paula Pujol-Fernández, Cristina Ujaldón-Miró, Irene García-Cadenas, Albert Esquirol, Rodrigo Martino, Jorge Sierra, Carmen Alvarez-Fernández, Javier Briones
Journal: Blood (2022)
Transient Responses and Significant Toxicities Due to Cytopenias and Rashes with Anti-CD30 CAR T Cells for CD30-Expressing Lymphomas: Results of a Phase I Clinical Trial
Authors: Jennifer N. Brudno, Jeremiah Karrs, Danielle Natrakul, Nisha Patel, Lekha Mikkilineni, Jennifer Mann, David F. Stroncek, Steven Highfill, Norris Lam, Genevieve C. Fromm, Rashmika Patel, Stefania Pittaluga, James N. Kochenderfer
Journal: Blood (2022)
Clinical Outcomes and Impact of Therapeutic Intervention in Patients (pts) with Acute Myeloid Leukemia (AML) with Recurrence of Measurable Residual Disease (MRD) after Achievement of MRD-Negative Remission
Authors: Walid Macaron, Farhad Ravandi, Tapan M. Kadia, Courtney D. DiNardo, Ghayas C. Issa, Naval Daver, Sa A Wang, Jeffrey L. Jorgensen, Keyur Patel, Sanam Loghavi, Marina Konopleva, Musa Yilmaz, Elias Jabbour, Abhishek Maiti, Hussein A Abbas, Elizabeth J Shpall, Uday R Popat, Gheath Alatrash, Sherry A. Pierce, Hagop Kantarjian, Nicholas Short
Journal: Blood (2022)